Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
6.83
+0.13 (1.87%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Amicus Therapeutics Employees
Amicus Therapeutics had 499 employees as of December 31, 2024. The number of employees decreased by 18 or -3.48% compared to the previous year.
Employees
499
Change (1Y)
-18
Growth (1Y)
-3.48%
Revenue / Employee
$1,058,707
Profits / Employee
-$112,437
Market Cap
2.10B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
FOLD News
- 4 weeks ago - Amicus Therapeutics Is Very Attractive At Current Prices (Rating Upgrade) - Seeking Alpha
- 6 weeks ago - In NCLA Amicus Win, D.C. Circuit Recognizes President Trump's Right to Fire Principal Officer - GlobeNewsWire
- 6 weeks ago - NCLA Amicus Brief Asks Fifth Circuit to Maintain Block Against Corporate Transparency Act - GlobeNewsWire
- 7 weeks ago - Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2025 - GlobeNewsWire
- 2 months ago - Amicus Therapeutics, Inc. (FOLD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates - GlobeNewsWire
- 2 months ago - Kuehn Law Encourages Investors of Amicus Therapeutics, Inc. to Contact Law Firm - GlobeNewsWire
- 2 months ago - Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025 - GlobeNewsWire